Back to Directory

Heather Sprenger

Email

sprenger@fstrf.org

Phone

716-834-0900 Ext. 7262

Institution

Frontier Science Foundation

Title

Laboratory Data Division Chief

Address

Frontier Science Foundation
4033 Maple Road
Amherst, NY 14226-1056
United States of America

Request an Update

Affiliated Studies

IMPAACT 2048/HVTN 145: Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Breastfeeding Infants.

DAIDS Number

TBA

Research Area

Treatment

Study Status

In Development

P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV

DAIDS Number

10316

Research Area

Other

Study Status

Concluded

P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents

DAIDS Number

10669

Research Area

Complications & Comorbidities

Study Status

Concluded

P1012: PK Study of Once Versus Twice Dosing with Combivir

DAIDS Number

10266

Research Area

Other

Study Status

Concluded

P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents

DAIDS Number

10037

Research Area

Treatment

Study Status

Concluded

Show All